Concepedia

Gerald Chu

GC

5

Publications

1.4K

Citations

5

H-Index

2007

Active since

Affiliations

Janssen (United States)(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Harvard University

Gerald Chu is an author at Janssen (United States) specializing in tumor biology, cell biology, and cancer biology.

ORCID

Top concepts

Publications per year

2007–2020

5

Publications

5

FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis

Ji-Hye Paik, Ramya Kollipara, Gerald Chu et al. · Cell · 2007 · 1K citations · Full text

, , +7

A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma

Kodandaram Pillarisetti, Suzanne C. Edavettal, Mark Mendonça et al. · Blood · 2020 · 156 citations · Full text

FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis

Boyi Gan, Carol S. Lim, Gerald Chu et al. · Cancer Cell · 2010 · 141 citations · Full text

, , +6

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

Priyanka Nair-Gupta, Michael Diem, Dara Reeves et al. · Blood Advances · 2020 · 43 citations · Full text

Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)

François Gaudet, Jennifer F. Nemeth, Ronan McDaid et al. · Blood · 2016 · 30 citations

Rows per page

1–5 of 5